Amanote Research
Register
Sign In
MECT1-MAML2 Fusion Transcript Defines a Favorable Subset of Mucoepidermoid Carcinoma
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-05-2376
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
July 1, 2006
Authors
M. Okabe
Publisher
American Association for Cancer Research (AACR)
Related search
CRTC1-MAML2 Gene Fusion in Mucoepidermoid Carcinoma of the Lacrimal Gland
Oncology Reports
Medicine
Cancer Research
Oncology
Primary Mucoepidermoid Carcinoma of the Liver With CRTC1-MAML2 Fusion: A Case Report
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
Genomic Profiles and CRTC1–MAML2 Fusion Distinguish Different Subtypes of Mucoepidermoid Carcinoma
Modern Pathology
Forensic Medicine
Pathology
The MECT1-MAML2 Gene Fusion and Benign Warthin's Tumor
Journal of Molecular Diagnostics
Forensic Medicine
Pathology
Molecular Medicine
MAML2 Rearrangement as a Useful Diagnostic Marker Discriminating Between Warthin Tumour and Warthin-Like Mucoepidermoid Carcinoma
Virchows Archiv
Medicine
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
Mucoepidermoid Carcinoma
Mucoepidermoid Carcinoma
Modern Research in Dentistry
Mucoepidermoid Carcinoma of Buccal Mucosa
BMJ Case Reports
Medicine
Clinicopathological Analysis of Pulmonary Mucoepidermoid Carcinoma
World Journal of Surgical Oncology
Surgery
Oncology